A detailed history of South Dakota Investment Council transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, South Dakota Investment Council holds 28,368 shares of VRTX stock, worth $11.6 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
28,368
Previous 33,843 16.18%
Holding current value
$11.6 Million
Previous $15.9 Million 16.83%
% of portfolio
0.26%
Previous 0.33%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$460.0 - $505.78 $2.52 Million - $2.77 Million
-5,475 Reduced 16.18%
28,368 $13.2 Million
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $380,632 - $470,478
-969 Reduced 2.78%
33,843 $15.9 Million
Q1 2024

May 02, 2024

SELL
$407.69 - $446.08 $978,456 - $1.07 Million
-2,400 Reduced 6.45%
34,812 $14.6 Million
Q4 2023

Feb 01, 2024

SELL
$343.0 - $410.68 $480,200 - $574,952
-1,400 Reduced 3.63%
37,212 $15.1 Million
Q3 2023

Nov 07, 2023

SELL
$338.18 - $362.46 $1.22 Million - $1.31 Million
-3,614 Reduced 8.56%
38,612 $13.4 Million
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $2.1 Million - $2.35 Million
-6,675 Reduced 13.65%
42,226 $14.9 Million
Q1 2023

May 10, 2023

BUY
$283.23 - $323.1 $368,199 - $420,030
1,300 Added 2.73%
48,901 $15.4 Million
Q4 2022

Feb 07, 2023

SELL
$285.76 - $321.48 $3.38 Million - $3.8 Million
-11,813 Reduced 19.88%
47,601 $13.7 Million
Q3 2022

Nov 09, 2022

SELL
$273.83 - $305.53 $4.95 Million - $5.52 Million
-18,075 Reduced 23.33%
59,414 $17.2 Million
Q2 2022

Aug 11, 2022

SELL
$234.96 - $292.55 $3.76 Million - $4.68 Million
-16,006 Reduced 17.12%
77,489 $21.8 Million
Q1 2022

May 10, 2022

SELL
$221.42 - $260.97 $6.82 Million - $8.04 Million
-30,799 Reduced 24.78%
93,495 $24.4 Million
Q4 2021

Feb 08, 2022

BUY
$177.01 - $223.45 $8.09 Million - $10.2 Million
45,680 Added 58.11%
124,294 $27.3 Million
Q3 2021

Nov 09, 2021

BUY
$181.39 - $202.99 $2.39 Million - $2.68 Million
13,200 Added 20.18%
78,614 $14.3 Million
Q2 2021

Aug 11, 2021

BUY
$187.49 - $221.1 $4.47 Million - $5.27 Million
23,820 Added 57.27%
65,414 $13.2 Million
Q1 2021

May 13, 2021

BUY
$207.02 - $241.31 $7.6 Million - $8.85 Million
36,694 Added 748.86%
41,594 $8.94 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $1.01 Million - $1.35 Million
4,900 New
4,900 $1.16 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track South Dakota Investment Council Portfolio

Follow South Dakota Investment Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.